Enliven Therapeutics Inc (ELVN)
Financing Cash Flow
$463.42M
Quarterly · Period ending: · USD
ELVN Financing Cash Flow
Latest reported$463.42Mperiod ending
Latest reported$463.42Mperiod ending
ELVN Quarterly Cash from Financing ($43.93M → $463.42M)
Quarterly financing cash flow
High-resolution chart · PNG
ELVN financing cash flow history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 463,418,000 | |
| 10,053,000 | |
| 623,000 | |
| -368,000 | |
| 218,378,000 | |
| 234,000 | |
| 39,972,000 | |
| 1,117,000 | |
| 1,806,000 | |
| 90,270,000 | |
| 90,000 | |
| -425,000 | |
| -2,820,000 | |
| 237,441,000 | |
| -2,377,000 | |
| 164,000 | |
| 5,000 | |
| 409,000 | |
| -10,000 | |
| 46,991,000 | |
| 1,660,000 | |
| 460,000 | |
| 597,000 | |
| 135,000 | |
| 9,593,000 | |
| 86,556,000 | |
| -1,996,000 | |
| 0 | |
| 1,648,000 | |
| 43,927,000 |